ID   MIP_HUMAN               Reviewed;         263 AA.
AC   P30301; Q17R41;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   15-MAR-2017, entry version 165.
DE   RecName: Full=Lens fiber major intrinsic protein;
DE   AltName: Full=Aquaporin-0;
DE   AltName: Full=MIP26;
DE            Short=MP26;
GN   Name=MIP; Synonyms=AQP0;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1840563; DOI=10.1016/0888-7543(91)90023-8;
RA   Pisano M.M., Chepelinsky A.B.;
RT   "Genomic cloning, complete nucleotide sequence, and structure of the
RT   human gene encoding the major intrinsic protein (MIP) of the lens.";
RL   Genomics 11:981-990(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION AT SER-235, DEAMIDATION AT ASN-246 AND ASN-259, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10634618;
RA   Schey K.L., Little M., Fowler J.G., Crouch R.K.;
RT   "Characterization of human lens major intrinsic protein structure.";
RL   Invest. Ophthalmol. Vis. Sci. 41:175-182(2000).
RN   [5]
RP   INVOLVEMENT IN CTRCT15, AND VARIANTS CTRCT15 GLY-134 AND ARG-138.
RX   PubMed=10802646; DOI=10.1038/75538;
RA   Berry V., Francis P., Kaushal S., Moore A., Bhattacharya S.;
RT   "Missense mutations in MIP underlie autosomal dominant 'polymorphic'
RT   and lamellar cataracts linked to 12q.";
RL   Nat. Genet. 25:15-17(2000).
RN   [6]
RP   INVOLVEMENT IN CTRCT15.
RX   PubMed=16564824; DOI=10.1016/j.ajo.2005.11.008;
RA   Geyer D.D., Spence M.A., Johannes M., Flodman P., Clancy K.P.,
RA   Berry R., Sparkes R.S., Jonsen M.D., Isenberg S.J., Bateman J.B.;
RT   "Novel single-base deletional mutation in major intrinsic protein
RT   (MIP) in autosomal dominant cataract.";
RL   Am. J. Ophthalmol. 141:761-763(2006).
RN   [7]
RP   FATTY ACYLATION.
RX   PubMed=27378310; DOI=10.1016/j.bbamem.2016.06.026;
RA   Ismail V.S., Mosely J.A., Tapodi A., Quinlan R.A., Sanderson J.M.;
RT   "The lipidation profile of aquaporin-0 correlates with the acyl
RT   composition of phosphoethanolamine lipids in lens membranes.";
RL   Biochim. Biophys. Acta 1858:2763-2768(2016).
RN   [8]
RP   VARIANTS CTRCT15 GLY-134 AND ARG-138.
RX   PubMed=11001937; DOI=10.1093/oxfordjournals.hmg.a018925;
RA   Francis P., Chung J.-J., Yasui M., Berry V., Moore A., Wyatt M.K.,
RA   Wistow G., Bhattacharya S.S., Agre P.;
RT   "Functional impairment of lens aquaporin in two families with
RT   dominantly inherited cataracts.";
RL   Hum. Mol. Genet. 9:2329-2334(2000).
RN   [9]
RP   VARIANT CTRCT15 CYS-33.
RX   PubMed=17893667;
RA   Gu F., Zhai H., Li D., Zhao L., Li C., Huang S., Ma X.;
RT   "A novel mutation in major intrinsic protein of the lens gene (MIP)
RT   underlies autosomal dominant cataract in a Chinese family.";
RL   Mol. Vis. 13:1651-1656(2007).
RN   [10]
RP   VARIANT CTRCT15 LYS-233.
RX   PubMed=17960133;
RA   Lin H., Hejtmancik J.F., Qi Y.;
RT   "A substitution of arginine to lysine at the COOH-terminus of MIP
RT   caused a different binocular phenotype in a congenital cataract
RT   family.";
RL   Mol. Vis. 13:1822-1827(2007).
RN   [11]
RP   VARIANT CTRCT15 ILE-107.
RX   PubMed=20361015;
RA   Wang W., Jiang J., Zhu Y., Li J., Jin C., Shentu X., Yao K.;
RT   "A novel mutation in the major intrinsic protein (MIP) associated with
RT   autosomal dominant congenital cataracts in a Chinese family.";
RL   Mol. Vis. 16:534-539(2010).
RN   [12]
RP   VARIANT CTRCT15 CYS-187.
RX   PubMed=21245956;
RA   Wang K.J., Li S.S., Yun B., Ma W.X., Jiang T.G., Zhu S.Q.;
RT   "A novel mutation in MIP associated with congenital nuclear cataract
RT   in a Chinese family.";
RL   Mol. Vis. 17:70-77(2011).
RN   [13]
RP   VARIANT CTRCT15 ASP-165, CHARACTERIZATION OF VARIANT CTRCT15 ASP-165,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=23116563; DOI=10.1016/j.exer.2012.10.010;
RA   Senthil Kumar G., Kyle J.W., Minogue P.J., Dinesh Kumar K.,
RA   Vasantha K., Berthoud V.M., Beyer E.C., Santhiya S.T.;
RT   "An MIP/AQP0 mutation with impaired trafficking and function underlies
RT   an autosomal dominant congenital lamellar cataract.";
RL   Exp. Eye Res. 110:136-141(2013).
RN   [14]
RP   VARIANT CTRCT15 CYS-33, CHARACTERIZATION OF VARIANT CTRCT15 CYS-33,
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=24120416; DOI=10.1016/j.exer.2013.09.019;
RA   Kumari S.S., Gandhi J., Mustehsan M.H., Eren S., Varadaraj K.;
RT   "Functional characterization of an AQP0 missense mutation, R33C, that
RT   causes dominant congenital lens cataract, reveals impaired cell-to-
RT   cell adhesion.";
RL   Exp. Eye Res. 116:371-385(2013).
RN   [15]
RP   VARIANT CTRCT15 HIS-150, CHARACTERIZATION OF VARIANT CTRCT15 HIS-150,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=25946197; DOI=10.1371/journal.pone.0126679;
RA   Shentu X., Miao Q., Tang X., Yin H., Zhao Y.;
RT   "Identification and functional analysis of a novel MIP gene mutation
RT   associated with congenital cataract in a Chinese family.";
RL   PLoS ONE 10:E0126679-E0126679(2015).
CC   -!- FUNCTION: Water channel (PubMed:24120416). Channel activity is
CC       down-regulated by CALM when cytoplasmic Ca(2+) levels are
CC       increased. May be responsible for regulating the osmolarity of the
CC       lens. Interactions between homotetramers from adjoining membranes
CC       may stabilize cell junctions in the eye lens core (By similarity).
CC       Plays a role in cell-to-cell adhesion and facilitates gap junction
CC       coupling (PubMed:24120416). {ECO:0000250|UniProtKB:Q6J8I9,
CC       ECO:0000269|PubMed:24120416}.
CC   -!- SUBUNIT: Homotetramer (PubMed:24120416). Homooctamer formed by
CC       head-to-head interaction between homotetramers from adjoining
CC       membranes. Interacts with CALM; one CALM molecule interacts with
CC       the cytoplasmic domains of two aquaporins, leading to channel
CC       closure (By similarity). {ECO:0000250|UniProtKB:P06624,
CC       ECO:0000269|PubMed:24120416}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23116563,
CC       ECO:0000269|PubMed:24120416, ECO:0000269|PubMed:25946197}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:Q6J8I9}. Cell
CC       junction, gap junction {ECO:0000269|PubMed:24120416}.
CC   -!- TISSUE SPECIFICITY: Major component of lens fiber gap junctions.
CC   -!- DOMAIN: Aquaporins contain two tandem repeats each containing two
CC       membrane-spanning helices and a pore-forming loop with the
CC       signature motif Asn-Pro-Ala (NPA). Each tandem repeat contains a
CC       loop and a short helix that enter and leave the lipid bilayer on
CC       the same side (By similarity). {ECO:0000250}.
CC   -!- PTM: Subject to partial proteolytic cleavage in the eye lens core.
CC       Partial proteolysis promotes interactions between tetramers from
CC       adjoining membranes (By similarity). {ECO:0000250}.
CC   -!- PTM: Fatty acylated at Met-1 and Lys-238. The acyl modifications,
CC       in decreasing order of ion abundance, are: oleoyl (C18:1) >
CC       palmitoyl (C16:0) > stearoyl (C18:0) > eicosenoyl (C20:1) >
CC       dihomo-gamma-linolenoyl (C20:3) > palmitoleoyl (C16:1) >
CC       eicosadienoyl (C20:2). {ECO:0000269|PubMed:27378310}.
CC   -!- DISEASE: Cataract 15, multiple types (CTRCT15) [MIM:615274]: An
CC       opacification of the crystalline lens of the eye that frequently
CC       results in visual impairment or blindness. Opacities vary in
CC       morphology, are often confined to a portion of the lens, and may
CC       be static or progressive. CTRCT15 includes polymorphic,
CC       progressive punctate lamellar, cortical, anterior and posterior
CC       polar, nonprogressive lamellar with sutural opacities, embryonic
CC       nuclear, and pulverulent cortical, among others.
CC       {ECO:0000269|PubMed:10802646, ECO:0000269|PubMed:11001937,
CC       ECO:0000269|PubMed:16564824, ECO:0000269|PubMed:17893667,
CC       ECO:0000269|PubMed:17960133, ECO:0000269|PubMed:20361015,
CC       ECO:0000269|PubMed:21245956, ECO:0000269|PubMed:23116563,
CC       ECO:0000269|PubMed:24120416, ECO:0000269|PubMed:25946197}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the MIP/aquaporin (TC 1.A.8) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U36308; AAC02794.2; -; Genomic_DNA.
DR   EMBL; AC024884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074913; AAH74913.1; -; mRNA.
DR   EMBL; BC117474; AAI17475.1; -; mRNA.
DR   CCDS; CCDS8919.1; -.
DR   PIR; A55279; A55279.
DR   RefSeq; NP_036196.1; NM_012064.3.
DR   UniGene; Hs.574026; -.
DR   ProteinModelPortal; P30301; -.
DR   SMR; P30301; -.
DR   BioGrid; 110430; 5.
DR   IntAct; P30301; 5.
DR   MINT; MINT-8415310; -.
DR   STRING; 9606.ENSP00000257979; -.
DR   iPTMnet; P30301; -.
DR   PhosphoSitePlus; P30301; -.
DR   BioMuta; MIP; -.
DR   DMDM; 266537; -.
DR   OGP; P30301; -.
DR   PaxDb; P30301; -.
DR   PeptideAtlas; P30301; -.
DR   PRIDE; P30301; -.
DR   DNASU; 4284; -.
DR   Ensembl; ENST00000257979; ENSP00000257979; ENSG00000135517.
DR   GeneID; 4284; -.
DR   KEGG; hsa:4284; -.
DR   UCSC; uc001slh.4; human.
DR   CTD; 4284; -.
DR   DisGeNET; 4284; -.
DR   GeneCards; MIP; -.
DR   HGNC; HGNC:7103; MIP.
DR   HPA; HPA014940; -.
DR   MalaCards; MIP; -.
DR   MIM; 154050; gene.
DR   MIM; 615274; phenotype.
DR   neXtProt; NX_P30301; -.
DR   OpenTargets; ENSG00000135517; -.
DR   Orphanet; 98985; Cataract with Y-shaped suture opacities.
DR   Orphanet; 98989; Cerulean cataract.
DR   Orphanet; 98991; Nuclear cataract.
DR   Orphanet; 98994; Total congenital cataract.
DR   Orphanet; 98995; Zonular cataract.
DR   PharmGKB; PA30821; -.
DR   eggNOG; KOG0223; Eukaryota.
DR   eggNOG; COG0580; LUCA.
DR   GeneTree; ENSGT00760000119223; -.
DR   HOGENOM; HOG000288286; -.
DR   HOVERGEN; HBG000312; -.
DR   InParanoid; P30301; -.
DR   KO; K09863; -.
DR   OMA; MWELRST; -.
DR   OrthoDB; EOG091G166T; -.
DR   PhylomeDB; P30301; -.
DR   TreeFam; TF312940; -.
DR   Reactome; R-HSA-432047; Passive transport by Aquaporins.
DR   SIGNOR; P30301; -.
DR   GeneWiki; MIP_(gene); -.
DR   GenomeRNAi; 4284; -.
DR   PMAP-CutDB; P30301; -.
DR   PRO; PR:P30301; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135517; -.
DR   CleanEx; HS_MIP; -.
DR   Genevisible; P30301; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005921; C:gap junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW.
DR   GO; GO:0015250; F:water channel activity; IDA:UniProtKB.
DR   GO; GO:1990349; P:gap junction-mediated intercellular transport; IDA:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0002088; P:lens development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   GO; GO:0006833; P:water transport; ISS:UniProtKB.
DR   CDD; cd00333; MIP; 1.
DR   Gene3D; 1.20.1080.10; -; 1.
DR   InterPro; IPR023271; Aquaporin-like.
DR   InterPro; IPR034294; Aquaporin_transptr.
DR   InterPro; IPR000425; MIP.
DR   InterPro; IPR022357; MIP_CS.
DR   PANTHER; PTHR19139; PTHR19139; 1.
DR   Pfam; PF00230; MIP; 1.
DR   PRINTS; PR00783; MINTRINSICP.
DR   SUPFAM; SSF81338; SSF81338; 1.
DR   TIGRFAMs; TIGR00861; MIP; 1.
DR   PROSITE; PS00221; MIP; 1.
PE   1: Evidence at protein level;
KW   Cataract; Cell junction; Cell membrane; Complete proteome;
KW   Disease mutation; Eye lens protein; Gap junction; Lipoprotein;
KW   Membrane; Palmitate; Phosphoprotein; Reference proteome; Repeat;
KW   Sensory transduction; Transmembrane; Transmembrane helix; Transport;
KW   Vision.
FT   CHAIN         1    263       Lens fiber major intrinsic protein.
FT                                /FTId=PRO_0000063912.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM      9     32       Helical. {ECO:0000250}.
FT   TOPO_DOM     33     38       Extracellular. {ECO:0000250}.
FT   TRANSMEM     39     61       Helical. {ECO:0000250}.
FT   INTRAMEM     62     67       {ECO:0000250}.
FT   INTRAMEM     68     78       Helical. {ECO:0000250}.
FT   TOPO_DOM     79     84       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     85    107       Helical. {ECO:0000250}.
FT   TOPO_DOM    108    126       Extracellular. {ECO:0000250}.
FT   TRANSMEM    127    147       Helical. {ECO:0000250}.
FT   TOPO_DOM    148    159       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    160    176       Helical. {ECO:0000250}.
FT   INTRAMEM    177    183       {ECO:0000250}.
FT   INTRAMEM    184    194       Helical. {ECO:0000250}.
FT   TOPO_DOM    195    200       Extracellular. {ECO:0000250}.
FT   TRANSMEM    201    219       Helical. {ECO:0000250}.
FT   TOPO_DOM    220    263       Cytoplasmic. {ECO:0000250}.
FT   REGION      227    237       Interaction with CALM. {ECO:0000250}.
FT   MOTIF        68     70       NPA 1.
FT   MOTIF       184    186       NPA 2.
FT   SITE        149    149       Important for water channel gating.
FT                                {ECO:0000250}.
FT   MOD_RES     235    235       Phosphoserine.
FT                                {ECO:0000269|PubMed:10634618}.
FT   MOD_RES     245    245       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06624}.
FT   MOD_RES     246    246       Deamidated asparagine; by deterioration.
FT                                {ECO:0000269|PubMed:10634618}.
FT   MOD_RES     259    259       Deamidated asparagine; by deterioration.
FT                                {ECO:0000269|PubMed:10634618}.
FT   VARIANT      33     33       R -> C (in CTRCT15; reduces cell-to-cell
FT                                adhesion, reduces cell-to-cell gap
FT                                junction coupling, no loss of cell
FT                                membrane localization, no loss of water
FT                                channel activity; dbSNP:rs864309693).
FT                                {ECO:0000269|PubMed:17893667,
FT                                ECO:0000269|PubMed:24120416}.
FT                                /FTId=VAR_071601.
FT   VARIANT     107    107       V -> I (in CTRCT15; dbSNP:rs74641138).
FT                                {ECO:0000269|PubMed:20361015}.
FT                                /FTId=VAR_071602.
FT   VARIANT     134    134       E -> G (in CTRCT15; non-progressive
FT                                lamellar cataract; loss of activity;
FT                                dbSNP:rs121917869).
FT                                {ECO:0000269|PubMed:10802646,
FT                                ECO:0000269|PubMed:11001937}.
FT                                /FTId=VAR_011497.
FT   VARIANT     138    138       T -> R (in CTRCT15; progressive
FT                                polymorphic and lamellar cataract; loss
FT                                of activity; dbSNP:rs121917867).
FT                                {ECO:0000269|PubMed:10802646,
FT                                ECO:0000269|PubMed:11001937}.
FT                                /FTId=VAR_011498.
FT   VARIANT     150    150       D -> H (in CTRCT15; loss of plasma
FT                                membrane expression).
FT                                {ECO:0000269|PubMed:25946197}.
FT                                /FTId=VAR_075528.
FT   VARIANT     165    165       G -> D (in CTRCT15; loss of plasma
FT                                membrane expression).
FT                                {ECO:0000269|PubMed:23116563}.
FT                                /FTId=VAR_075529.
FT   VARIANT     187    187       R -> C (in CTRCT15; dbSNP:rs267603585).
FT                                {ECO:0000269|PubMed:21245956}.
FT                                /FTId=VAR_071603.
FT   VARIANT     233    233       R -> K (in CTRCT15).
FT                                {ECO:0000269|PubMed:17960133}.
FT                                /FTId=VAR_071604.
SQ   SEQUENCE   263 AA;  28122 MW;  6A864C8AA53CBC4B CRC64;
     MWELRSASFW RAIFAEFFAT LFYVFFGLGS SLRWAPGPLH VLQVAMAFGL ALATLVQSVG
     HISGAHVNPA VTFAFLVGSQ MSLLRAFCYM AAQLLGAVAG AAVLYSVTPP AVRGNLALNT
     LHPAVSVGQA TTVEIFLTLQ FVLCIFATYD ERRNGQLGSV ALAVGFSLAL GHLFGMYYTG
     AGMNPARSFA PAILTGNFTN HWVYWVGPII GGGLGSLLYD FLLFPRLKSI SERLSVLKGA
     KPDVSNGQPE VTGEPVELNT QAL
//
